TokenPost·
Injective and BDACS Name KRW1 as Planned Sole Won Settlement Asset
The memorandum limits minting and redemption on Injective to approved institutional partners and makes both actions subject to regulatory approval.
More news
- TokenPostSalus CMO Flags Suspected $16 Million CoinDCX Theft Involving USDT, TRX
- TokenPostSix Blockchain Groups Seek SEC Presumption for Digital Commodity Resales
- Bitcoin MagazineUtexo Opens Utexo Mint Early Access for USDT on Bitcoin Ahead of November 28 Launch
- TokenPostCoinDCX Wallets Send $16 Million to Addresses From July 2025 Hack
- CoinGapeSPCX Stock Price Falls 5% as $200B in SpaceX Shares Unlock for Trading
- TokenPostLiquid Capital Founder Says Midterms Could Bring Larger Market Swings